NRP2 Antibody - #DF7032

Fig. 5Npn-2 controls axon collateral formation. A Npn-2 knockdown by shNpn-2 validated in primary neuron cultures by western blot using an antibody for rat Npn-2. B Quantitation of Npn-2 in A, n = 3, ***P = 0.0003. C hNpn-2 expression validated by western blot. Expression of hNpn-2 in neurons was detected by western blot using an anti-Flag antibody, showing that the expression of human full-length Npn-2 cannot be affected by the rat shNpn-2 used. D Quantitation of Npn-2 in C, n = 3, P > 0.05. E Neonatal rat primary hippocampal neurons were transfected with shCtrl, shNpn-2, or shNpn-2 plus hNpn-2 plasmids at DIV 0 and treated with either control medium or Sema3F (5 nM) at 48 h after transfection for 24 h. Axons and their collaterals were detected by immunofluorescent staining with GFP and Tau-1. Arrows indicate main axons and stars indicate axon collaterals. Scale bar, 40 μm. F, G Quantitation of axon collateral number and length in E. Sema3F treatment reduced the number and length of axon collaterals in neurons transfected with shCtrl but not in neurons with shNpn-2 transfection, which was rescued by hNpn-2 co-transfection. *P < 0.05, **P < 0.01. H Quantitation of main axon length in E. Main axon elongation in neurons transfected with shCtrl was inhibited upon Sema3F treatment, but not in neurons with shNpn-2 transfection, which was rescued by hNpn-2 expression. **P < 0.01, ***P < 0.001. One-way ANOVA, post hoc Tukey test. Error bars represent SEM